Dr. Danilo González-Nilo, a lead researcher from Universidad Andrés Bello (UNAB), presented the final results of his scientific research project titled “Rational Design of Novel Pain Inhibitors” on December 9 and 10 at the U.S. Army Research Laboratory (ARL), and at the U.S. Army Medical Research and Materiel Command (MRMC) respectively.
The project was funded by the U.S. Army Research, Development, and Engineering Command – Americas (RDECOM-AME) office in Santiago. Its mission is to identify international collaborative research opportunities in science and technology development. RDECOM-AME is a major subordinate command of the U.S. Army Materiel Command.
González-Nilo’s research group was able to screen, identify and test two novel molecules to block pain trough nerve channels. The research seeks to improve current pain medications by developing a novel medical treatment for pain that will allow patients to remain conscious during treatment, and therefore assist medical teams in the diagnosis and treatment of other life-threatening conditions.
The project results were of high technical merit and fostered a great information exchange between Dr. González-Nilo and U.S. Army Scientists who conduct research in this field.
Several potential future research projects in the fields of neuroscience, biopolymers and dendrimers resulted from this face-to-face interaction. Additionally, the teams explored the potential for scientist exchanges between the U.S. Army Research Laboratory and Universidad Andrés Bello.
